What is Invictus MD Strategies Corp. (IVITF)?

Invictus MD Strategies Corp. (IVITF) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

What is the current price of IVITF?

The current price of IVITF is $0.00. Prices are updated in real time on Stocks360.

What is IVITF's price-to-earnings (PE) ratio?

IVITF's trailing twelve-month PE ratio is -0.00, based on current price and earnings per share data available on Stocks360.

What is IVITF's market capitalization?

IVITF's market capitalization is $4,453,220.00, placing it in the small-cap tier.

Invictus MD Strategies Corp. (IVITF)

Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic

$0.00

Market Cap

$4.45M

PE (TTM)

-0.00

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.70

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

275.95K

Invictus MD Strategies Corp. (IVITF) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $4.45M. Trailing PE -0.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Dec 22, 2017

EPS $-0.03 vs est. $-0.02

Missed by $0.01

Proprietary Signals

Signal snapshot temporarily unavailable.

About Invictus MD Strategies Corp.

Invictus MD Strategies Corp. is a Canadian firm primarily focused on strategic investments, acquisitions, and the development of complementary enterprises within the country's cannabis sector. The company's operations are divided into two main areas: cannabis sales and fertilizers. Its cannabis division is involved in the cultivation and distribution of medical cannabis. Concurrently, its fertilizer segment offers hydroponic plant fertilizers, nutrient solutions, and various other supplies essential for cultivation. Additionally, Invictus MD Strategies Corp. manages medical clinics situated in Alberta. The company was established in 2014 and maintains its principal office in Vancouver, Canada.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.00×
P/S (TTM)	1.74×
P/B	0.00×
P/FCF (TTM)	-0.18×
EV / EBITDA	-0.36×
EV / Sales	3.36×
Earnings Yield	-191831.01%
Free Cash Flow Yield	-560.97%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$12.00M
Revenue (TTM)	$3.57M
Net Income (TTM)	-$11.92B
Free Cash Flow (TTM)	-$34.63M
Net Debt	$5.78M
Working Capital	$13.78M
Gross Margin	-80.99%
Operating Margin	-694.62%
Net Margin	-761.00%
Return on Equity	-31.91%
Return on Invested Capital	-20.70%